{
    "nctId": "NCT00579488",
    "briefTitle": "Clinical Significance of Germline BRCA Mutations",
    "officialTitle": "Clinical Significance of Germline BRCA Mutations",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Cancer, Ovarian Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 13320,
    "primaryOutcomeMeasure": "To obtain DNA samples",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Families referred for genetic counseling consultation at Memorial Hospital\n* Individuals self-referred or physician referred for genetic counseling due to a concern about increased risk for breast cancer, regardless of family history or ethnic origin.\n* Individuals enrolled in MSK protocol 97-029 \"Germline BRCA1 and BRCA2 mutations in Jewish Women Affected by Breast Cancer\"\n* Individuals who present for genetic counseling consultation at Memorial Hospital after undergoing genetic testing at an outside institution.\n* Member of a family with breast cancer who wishes to provide a DNA sample for research purposes\n* Individuals enrolled on protocol 12-245 with germline variants in genes associated with risk for breast or ovarian cancer, or absent such variants in the presence of a family history or other phenotypic features of interest including but not limited to: triple negative breast cancer, early onset of disease, and/or synchronous or metachronous breast and ovarian cancer.\n\nExclusion Criteria:\n\n-Patients will be excluded from this study if: he/she has physical, cognitive or psychiatric conditions that interfere with ability to give meaningful informed consent; he/she cannot read, write or communicate in English; he/she is less than 18 years of age.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}